Shares of pharmaceutical companies Novo Nordisk and Eli Lilly slid after Roche announced results from a promising early-stage trial for its proposed obesity drug.

A new study published in JAMA Ophthalmology suggests that taking Ozempic or Wegovy may increase the risk of developing a rare form of blindness.

President Joe Biden and Senator Bernie Sanders have urged Novo Nordisk and Eli Lilly to lower the prices of their popular weight loss drugs.

Novo Nordisk announced a $4.1 billion investment to build a new manufacturing plant in Clayton, North Carolina, to increase production capacity for its popular drugs Wegovy, Ozempic, and other injectable therapies.

Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate following Sen. Bernie Sanders' threat to subpoena the company over the pricing of diabetes drug Ozempic and obesity drug Wegovy.

Telehealth startup Ro has launched a free online tracker to help patients and doctors locate in-stock weight-loss drugs like Wegovy amid national shortages, providing real-time availability and the option to report outages to the FDA.

Amgen witnessed an impressive 12% surge in its shares on Friday, marking its most substantial single-day increase in nearly 15 years.

The Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust collaborated to solve global health concerns using science and technology.

Novo Nordisk exceeded profit expectations in Q1 2024 with a 28% surge in net profit, driven by Wegovy's success.

A recent study suggests that Novo Nordisk's diabetes drug, Ozempic, priced at nearly $1,000 in the US, could be produced for less than $5 a month.